New Standards of Care for CRMD Antibiotic Protection

NACCME

Sponsored by the North American Center for Continuing Medical Education (NACCME)

Target Audience

Physicians, nurses and technologists

Learning Objectives

Upon completion of this educational activity, participants should be able to:

address the pathogenesis of infections associated with pacemakers and defibrillators
assess the anti-infective efficacy of potentially preventive approaches
describe the risks and costs associated with resolving device-related infections.

Activity Overview

The Interactive Web Symposia will be presented live on 2 dates on November 18, 2008 and November 19, 2008 by Rabih O. Darouiche, MD and Charles J. Love, MD . Participants will be provided with access instructions via email prior to the live presentation. A score of 70 percent or above will comprise a passing grade. A documentation of credit will be awarded to participants who successfully complete the exam. Those who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

There is no fee for the activity.

CME Accreditation

This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

CNE Accreditation

NACCME is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour (Provider Number 110-3-E-06). Provider approved by the California Board of Registered Nursing, Provider Number 13255, for 1 contact hour.

Technologists

AHRA-Approved for 1 Category A, ARRT continuing education credit

Release Date: October 1, 2008

Expiration Date: October 1, 2009

Estimated time to complete: 1 hour

Lecture Components

The audio/video presentation, post-test, and evaluation form will be available to you at the time of the live broadcast via a link that will be sent to your e-mail address after registration.

Participating Faculty

Rabih O. Darouiche, MD
Topic: Prevention of Device-Related Infections
VA Distinguished Service Professor
Director, Center for Prostheses Infection
Baylor College of Medicine
Houston, Texas

Charles J. Love, MD
Topic: Current Trends in Implantable Device Infection and Management
Professor of Clinical Medicine
Division of Cardiovascular Medicine
Ohio State University Medical Center
Director, Arrhythmia Device Services and Associate Investigator
Dorothy M. Davis Heart & Lung Research Institute
Columbus, Ohio

Grant Support

This activity is supported by an educational grant from TyRx Pharma, Inc..

Disclosures

All those in a position to control content of continuing education programs sponsored by NACCME, LLC are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All conflicts of interest thatare identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Dr. Love has disclosed that he has received grant/research support from Boston Scientific, St. Jude Medical, Medtronic, and Biotronik. He is a consultant to Medtronic and TyRx. He is a scientific advisor to TyRx, Spectranetics, and Deringer-Ney. He is a member of the speakers’ bureau for Spectranetics. Dr. Darouiche has disclosed that he is a consultant to TyRx Pharma.

Representatives of the granting organization may not register on behalf of participants.